Janux Therapeutics, Inc.

44
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US47103J1051
USD
16.40
0.54 (3.4%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Operating Income
10.00
8.00
8.00
3.00
0.00
0.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
10.00
8.00
8.00
3.00
0.00
0.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
0.00
0.00
0.00
0.00
0.00
0.00
General and Administration Expenses
38.00
24.00
21.00
10.00
1.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
109.00
81.00
75.00
36.00
4.00
3.00
Operating Profit (PBDIT) excl Other Income
-98.00
-72.00
-67.00
-32.00
-4.00
-3.00
Other Income
29.00
14.00
4.00
0.00
0.00
0.00
Operating Profit (PBDIT)
-66.00
-56.00
-62.00
-32.00
-4.00
-3.00
Interest
0.00
0.00
0.00
0.00
0.00
0.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
2.00
1.00
0.00
0.00
0.00
0.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
-68.00
-58.00
-63.00
-32.00
-6.00
-4.00
Provision for Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-68.00
-58.00
-63.00
-32.00
-6.00
-4.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
-1.28
-1.32
-1.52
-0.79
-0.16
-0.10
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 30.99% vs -6.14% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is -35.45% vs -8.78% in Dec 2023

stock-summary

Interest

No Interest in the last few periods;

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2024 is -18.36% vs 7.56% in Dec 2023

Compare Profit and Loss Results of Janux Therapeutics, Inc.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
Operating Income
10.00
10.00
0.00
0.00%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
10.00
10.00
0.00
0.00%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
0.00
0.00
0.00
0%
General and Administration Expenses
38.00
83.00
-45.00
-54.22%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
109.00
389.00
-280.00
-71.98%
Operating Profit (PBDIT) excl Other Income
-98.00
-378.00
280.00
74.07%
Other Income
29.00
56.00
-27.00
-48.21%
Operating Profit (PBDIT)
-66.00
-319.00
253.00
79.31%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
2.00
2.00
0.00
0.00%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-68.00
-322.00
254.00
78.88%
Provision for Tax
0.00
0.00
0.00
0%
Profit After Tax
-68.00
-322.00
254.00
78.88%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-1.2836
-2.8885
1.60
55.56%
Profit And Loss - Net Sales
Net Sales 10.59 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 30.99% vs -6.14% in Dec 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -98.85 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -35.45% vs -8.78% in Dec 2023

Profit And Loss - Interest
Interest 0.00 Million
in Dec 2024

Figures in Million
stock-summary

No Interest in the last few periods;

Profit And Loss - Profit After Tax
Profit After Tax -68.99 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -18.36% vs 7.56% in Dec 2023